OXNXF
Onxeo SA

1
Mkt Cap
$29.82M
Volume
565.00
52W High
$0.67
52W Low
$0.67
PE Ratio
-8.08
OXNXF Fundamentals
Price
$0.67
Prev Close
$0.8343
Open
$0.67
50D MA
$0.67
Beta
0.00
Avg. Volume
0.00
EPS (Annual)
-$0.1682
P/B
1.64
Rev/Employee
$55,413.49
Loading...
Loading...
Valerio Therapeutics SA is a is a clinical-stage biotechnology company, which engages in the development of oncology drugs targeting tumor intracellular processes. The firm produces and develops orphan oncology products under the brand names Livatag, Validive, Beleodaq and AsiDNA. The company was founded by Jean Theron, Gilles Avenard, and Dominique Costantini on March 5, 1997 and is headquartered in Paris, France.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
35

Frequently Asked Questions

What is Market Cap of Onxeo SA?
What is the 52-week high for Onxeo SA?
What is the 52-week low for Onxeo SA?
What is Onxeo SA stock price today?
What was Onxeo SA stock price yesterday?
What is the PE ratio of Onxeo SA?
What is the Price-to-Book ratio of Onxeo SA?
What is the 50-day moving average of Onxeo SA?
How many employess does Onxeo SA has?

Latest OXNXF News

View
No OXNXF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.